Acesso Livre1

POLIOMIELITE

(1)
AYUKEKBONG, J. A; BERGSTROM, T. Polio will go, acute flaccid paralysis will stay. Lancet, London, v. 383, n. 9936, p. 2209-2210, Jun. 2014.

Leia o artigo

Acesso Livre 2

(2)
BUTAN, C. ; FILMAN, D. J. ; HOGLE, J. M. Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release.Journal virology, Washington, v. 88, n. 3, p. 1757-1770, Feb. 2014.

Leia o artigo

(3)
CAETANO, L. P. et al. Polio and the risk for the European Union. Lancet, London, v. 383, n. 9913, p. 216-217, Jan. 2014.

Leia o artigo

(4)
DURANTE, A. L. T. C; POZ, M. R. D. Saúde global e responsabilidade sanitária brasileira: o caso da erradicação da poliomielite. Saúde em debate, Rio de Janeiro, v. 38, n. 100, p. 129-13, jan.-mar. 2014.

Leia o artigo

(5)
LIRA, C. A. B; ANDRADE, M. S; VANCINI, R. L. Poliomyelitis: a new old disease. What is the value of continuing education programs for health professionals? Arquivos neuro-psiquiatria, São Paulo, v. 72, n. 7, Jul. 2014.

Leia o artigo

(6)
LYCKE, E; MAGNIUS, L. O; NORDER, H. Should we use oral polio vaccine in Europe? Lancet, London, v. 383, n. 9922, p. 1037-1038, mar. 2014.

Leia o artigo

(7)
OBERSTE, M. S; LIPTON, H. L. Global polio perspective. Neurology, Minneapolis, v. 82, p. 1831-1832, May 2014.

Leia o artigo

(8)
PERSISTENCE of poliomyelitis in Nigeria. Lancet, London, v. 2, feb 2014.

Leia o artigo

(9)
SMALLMAN-RAYNOR, M. R, CLIFF, A. D. Abrupt transition to heightened poliomyelitis epidemicity in England and Wales, 1947–1957, associated with a pronounced increase in the geographical rate of disease propagation. Epidemiology Infection, Cambridge, v. 142, n. 3, p. 577-591, 2014.

Leia o artigo

(10)
YAMAYOSHI, S; FUJI, K; KOIKE, S. Receptors for enterovirus 71. Emerging Microbes and Infections, v. 3, e53, Jul. 2014.

Leia o artigo